-
DOPE: Membrane Fusion, Lipidomics & Assay Design
2026-09-15
Explore how 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) supports endosomal membrane fusion and how phospholipid research in rice blast fungus informs better assay controls. This guide connects delivery formulation, lipidomics, and practical handling of C4956.
-
Sulfo-NHS-LC-Biotin: Practical Workflow Guide
2026-09-15
Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to streptavidin-based capture or detection, but not to reversible labeling or routine intracellular biotinylation.
-
AG-490: Mapping JAK2/STAT6 in Tumor Immunity
2026-09-14
AG-490 (Tyrphostin B42) can serve as a mechanistic perturbation tool for testing JAK2-linked signaling in exosome-driven macrophage polarization. This guide explains how to interpret its overlapping JAK2, EGFR, ErbB2, STAT, and MAPK activities when designing cancer research assays.
-
CH 223191 for AhR Pathway Workflows
2026-09-14
CH 223191 is a nanomolar aryl hydrocarbon receptor antagonist for separating AhR-dependent transcription from microbiota, ligand, and inflammatory effects. This workflow-focused guide covers dose selection, intestinal and toxicology applications, controls, and troubleshooting for reproducible pathway studies.
-
Firefly Luciferase mRNA: R1013 Guide
2026-09-13
Firefly Luciferase mRNA R1013 combines Cap1 capping, 5-moUTP modified mRNA chemistry, and an optimized poly(A) tail for research-scale reporter expression. Its defined transcript length, formulation, and handling requirements support reproducible mRNA delivery and translation efficiency assays.
-
Cand2, Ubiquitination, and Fungal Pathogenicity
2026-09-12
The reference study identifies MoCand2 as a conserved fungal inhibitor of Cullin-RING ligase activity and connects this function to TOR stability, autophagy, and rice blast pathogenicity. Its genetic and biochemical framework provides a useful model for studying how ubiquitination–autophagy imbalance alters fungal development and virulence.
-
DiscoveryProbe Protease Inhibitor Library Workflows
2026-09-12
Build reproducible biochemical, cellular, and high-content screens with 825 pre-dissolved protease inhibitors covering cysteine, serine, and proteasome targets. The workflow connects protease activity modulation to apoptosis assay development, cancer research, infectious disease research, and mechanistic studies inspired by dynamic DNA-defense biology.
-
Multianimal MRI for Pancreatic Tumor Monitoring
2026-09-11
Kempinska et al. present a four-chamber MRI workflow that images up to four KPC pancreatic cancer mice in one high-resolution acquisition. The approach reduces imaging time and cost while supporting tumor enrollment, longitudinal growth monitoring, and proof-of-concept assessment of gemcitabine response.
-
Intestinal TM6SF2 Protects Against MASH
2026-09-11
This reference study identifies intestinal TM6SF2 as a protective regulator of the gut–liver axis, linking epithelial lipid handling to barrier integrity, microbial composition, lysophosphatidic acid transfer, and hepatic inflammation. Its combination of conditional genetics, microbiota transfer, cohousing, and receptor pharmacology provides a mechanistic framework for studying MASH beyond the liver itself.
-
Superoxide Dismutase (SOD) Activity Assay Kit
2026-09-10
The Superoxide Dismutase (SOD) Activity Assay Kit, SKU K2035, provides a colorimetric method for quantifying functional SOD activity in biological fluids through WST-1 reduction by superoxide generated with xanthine oxidase. It is intended for research workflows involving oxidative stress and antioxidative enzyme analysis, not for diagnosis, medical decisions, or unvalidated sample matrices.
-
PAD4-IN-2 TFA: Tumor-Targeted PAD4 Inhibition
2026-09-10
PAD4-IN-2 TFA, also called Compound 5i TFA, is a meta-phenylboronic acid-modified PAD4 inhibitor for cancer research. Preclinical evidence links it to reduced histone H3 citrullination, NET formation, tumor growth, and lung metastasis with favorable mouse safety markers.
-
InstaBlue Protein Stain Solution Guide
2026-09-09
InstaBlue Protein Stain Solution provides rapid, fixation-free visualization of protein bands in polyacrylamide gels using a ready-to-use Coomassie Brilliant Blue formulation. It is suited to routine protein electrophoresis analysis and workflows that may lead to mass spectrometry, but detection limits, densitometric linearity, and downstream recovery should be validated for each gel system and sample type.
-
AM 281: A CB1 Receptor Antagonist Workflow
2026-09-09
AM 281 enables selective interrogation of CB1 signaling in traumatic brain injury, astrocyte–neuron assays, and memory impairment research. This workflow connects receptor pharmacology with GLT-1, CREB, excitotoxicity, and behavioral endpoints while emphasizing formulation controls and time-resolved sampling.
-
Rapid Recombinant Annexin V Purification: Study Analysis
2026-09-08
The 1993 study introduced a short, selective purification strategy for recombinant annexin V by combining mild osmotic cell opening, calcium-dependent liposome binding, and final ion-exchange chromatography. Its main contribution was not a new annexin mechanism, but a practical way to obtain sufficiently pure protein for crystallography, electron microscopy, spectroscopy, and electrophysiological measurements.
-
KU-60019: ATM Kinase Inhibitor Workflows
2026-09-08
KU-60019 combines high ATM selectivity with practical use in glioma radiosensitization, DNA repair studies, and migration assays. This guide translates its mechanism into reproducible workflows, assay controls, and troubleshooting strategies while connecting the product to emerging research on lncRNA-mediated ATM regulation.